Cargando…
Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?
Autores principales: | Tasoulas, Jason, Sheth, Siddharth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174831/ https://www.ncbi.nlm.nih.gov/pubmed/37180661 http://dx.doi.org/10.21037/tcr-23-59 |
Ejemplares similares
-
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma
por: Huber, Gerhard Frank
Publicado: (2021) -
Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
por: Faraji, Farhoud, et al.
Publicado: (2023) -
Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas
por: Levidou, Georgia, et al.
Publicado: (2018) -
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023) -
Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
por: Dean, Nichole R., et al.
Publicado: (2011)